Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the Oncology Precision Medicine Sector?

The size of the oncology precision medicine market has experienced quick growth in the past few years. Its growth trajectory is projected to accelerate from $110.90 billion in 2024 to $125.14 billion in 2025, charting a compound annual growth rate (CAGR) of 12.8%. The growth seen during the historic period is credited to the increasing incidence of cancer, escalating adoption of targeted treatments, larger investment in genetic research, enhanced healthcare infrastructure and growing awareness about individualized medicine.

The market for precision oncology is projected to experience substantial growth in the upcoming years, escalating to a value of $201.40 billion in 2029 with a compound annual growth rate (CAGR) of 12.6%. This accelerated growth during the prediction period can be credited to an escalating demand for non-invasive cancer diagnostic procedures, increased inclination towards personalized treatment modalities, the rising usage of companion diagnostics, the growth of the precision oncology drug pipeline, and more prolific clinical use of artificial intelligence tools. Key trends observed during this period encompass advancements in liquid biopsy technology, novel innovations in next-generation sequencing, progress in artificial intelligence for data analysis, creation of new biomarkers through research and development, and the incorporation of multi-omics in clinical oncology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25853&type=smp

What Forces Are Driving The Growth Of The Oncology Precision Medicine Market?

The continual rise in cancer rates is set to boost the expansion of the oncology precision medicine market. Cancer, a disease characterized by the uncontrolled growth and spread of abnormal cells, can severely disrupt the body’s normal functions. Factors contributing to the increasing cancer rates include ageing populations and the inherent consequences such as the build-up of DNA mutations, breakdown of repair mechanisms, persistent inflammaging, weakened immune surveillance, and alterations in tissue microenvironments that augment tumor progression. Oncology precision medicine significantly contributes to cancer treatment, providing personalized medical approaches tailored to the distinct genetic composition of each tumor, thereby increasing efficacy and limiting side effects. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, projected that the 20 million cancer cases recorded in 2022, are anticipated to surge by 77% to exceed 35 million cases by 2050. Thus, the increasing cancer rates are a key factor propelling the growth of the oncology precision medicine market.

How Is The Oncology Precision Medicine Industry Segmented Across Key Parameters?

The oncology precision medicine market covered in this report is segmented –

1) By Product Type: Diagnostics, Therapeutics, Inhibitor Drugs, Monoclonal Antibodies, Cell And Gene Therapy, Antiviral And Anti-Retroviral Drugs

2) By Technology: Genomics, Proteomics, Bioinformatics, Other Technologies

3) By Biomarker Types: Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Other Biomarker Types

4) By Applications: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Bladder Cancer, Other Applications

5) By End-Users: Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Diagnostics: Companion Diagnostics, Molecular Diagnostics, Liquid Biopsy, Imaging Diagnostics, Next-Generation Sequencing Assays

2) By Therapeutics: Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)

3) By Inhibitor Drugs: Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)

4) By Monoclonal Antibodies: Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors, Radiolabeled Antibodies

5) By Cell And Gene Therapy: CAR-T Cell Therapies, T-Cell Receptor (TCR) Therapies, Tumor-Infiltrating Lymphocyte (TIL) Therapies, Oncolytic Viral Therapies, Gene Editing And Replacement Therapies

6) By Antiviral And Anti-Retroviral Drugs: Reverse Transcriptase Inhibitors, Protease Inhibitors, Integrase Strand Transfer Inhibitors, Entry Inhibitors, Antiviral Agents Targeting Virus-Related Cancers

What Upcoming Trends Are Expected To Impact The Oncology Precision Medicine Market Globally?

Major players in the oncology precision medicine market, such as molecular tumor board programs, are creating cutting-edge solutions to promote cooperative efforts between multiple disciplines and streamline bespoke treatment planning. Molecular tumor boards consist of interdisciplinary specialists who examine and decode intricate genomic and molecular testing results to suggest individualized cancer treatment approaches. For example, in April 2025, the American healthcare services and IT firm, McKesson Corporation, introduced the Precision Care Companion initiative. Through this program, they aim to back biomarker-led cancer treatment by offering education, technological updates, and administrative support to oncology practices. This exhaustive scheme consolidates doctors, clinical personnel, business heads, and pharma associates to establish a synergistic atmosphere that accelerates the assimilation of sophisticated genomic testing and targeted treatments. This assists in providing more personalized and efficient cancer therapies, thereby enhancing patient outcomes.

Which Companies Currently Dominate The Competitive Landscape In The Oncology Precision Medicine Industry?

Major companies operating in the oncology precision medicine market are Roche Holding AG, Bristol Myers Squibb Company, Abbott Laboratories, Novartis AG, Gilead Sciences Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., Exact Sciences Corporation, Almac Group Limited, OPKO Health Inc., Natera Inc., Myriad Genetics Inc., Pacific Biosciences of California Inc., Asuragen Inc., BGI Group, ANGLE plc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/oncology-precision-medicine-global-market-report

Which Geographic Regions Are Driving Demand In The Oncology Precision Medicine Market?

North America was the largest region in the oncology precision medicine market in 2024. The regions covered in the oncology precision medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25853&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model